Model containing sarcopenia and visceral adiposity can better predict the survival of hepatocellular carcinoma: A multicenter study
preprint
OA: closed
CC-BY-4.0
Abstract
Aim: This study aimed to explore whether the addition of sarcopenia and visceral adiposity could improve the accuracy of model predicting progression-free survival (PFS) in hepatocellular carcinoma (HCC). Methods: : In total, 394 patients with HCC from five hospitals were divided into the training and external validation datasets. Patients were initially treated by liver resection or transarterial chemoembolization. We evaluated adipose and skeletal muscle using preoperative computed tomography imaging and then constructed three predictive models, including metabolic (Model MA ), clinical–imaging (Model CI ), and combined (Model MA-CI ) models. Their discrimination, calibration, and decision curves were compared, to identify the best model. Nomogram and subgroup analysis was performed for the best model. Results: : Model MA-CI containing sarcopenia and visceral adiposity had good discrimination and calibrations(area under the curve for three-year PFS was 0.792in the training data set and 0.817 in the validation data set;similar results were achieved in one- and two-year PFS). Model MA-CI had better accuracy than Model CI and Model MA . The performance of Model MA-CI was not affected by treatments or disease stages. The high-risk subgroup(scored≥120) had a significantly shorter PFS (p<0.001) and poorer OS (p<0.001). Conclusions: : The addition of sarcopenia and visceral adiposity improved accuracy in predicting PFS in HCC, which may provide additional insights in prognosis for HCC in subsequent studies.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (32)
- doi:10.3322/caac.21660 via crossref
- doi:10.1148/radiol.2019181818 via crossref
- doi:10.1001/jamaoncol.2019.4477 via crossref
- doi:10.1200/jco.2014.57.9151 via crossref
- doi:10.1002/jcsm.13040 via crossref
- doi:10.1159/000488779 via crossref
- doi:10.1002/hep.29578 via crossref
- doi:10.1177/10732748211038445 via crossref
- doi:10.21037/jgo-20-341 via crossref
- doi:10.1016/j.cmpb.2021.106288 via crossref
- doi:10.1016/j.jhep.2017.03.021 via crossref
- doi:10.1200/jco.20.02672 via crossref
- doi:10.1055/s-0030-1247132 via crossref
- doi:10.1016/j.jhep.2012.08.017 via crossref
- doi:10.1016/j.jhep.2015.02.031 via crossref
- doi:10.1002/jhbp.236 via crossref
- doi:10.1007/s00268-016-3504-3 via crossref
- doi:10.1111/liv.14755 via crossref
- doi:10.1159/000508867 via crossref
- doi:10.1118/1.2794176 via crossref
- doi:10.1016/j.jhep.2021.11.018 via crossref
- doi:10.1016/j.bbcan.2019.188326 via crossref
- doi:10.1056/nejmsr1606602 via crossref
- doi:10.1002/hep.28316 via crossref
- doi:10.1016/j.clnu.2018.09.019 via crossref
- doi:10.1002/jcsm.12018 via crossref
- doi:10.1186/s12986-019-0405-0 via crossref
- doi:10.1152/ajpendo.00092.2011 via crossref
- doi:10.1245/s10434-016-5668-3 via crossref
- doi:10.1016/j.freeradbiomed.2018.08.035 via crossref
- doi:10.1186/1471-2407-14-643 via crossref
- doi:10.1016/j.ejrad.2016.12.030 via crossref
Source provenance
- crossref
- last seen: 2026-06-13T06:42:39.987704+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0